Infliximab treatment maintains employability in patients with early rheumatoid arthritis.

Josef S Smolen; Chenglong Han; Désirée van der Heijde; Paul Emery; Joan M Bathon; Edward Keystone; Joachim R Kalden; Michael Schiff; Mohan Bala; Daniel Baker

doi:10.1002/art.21661

Infliximab treatment maintains employability in patients with early rheumatoid arthritis.

Identifier:nobleid.org/w1/20260515/332FCBFD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/332FCBFD.svg?ark=w1%2F20260515%2F332FCBFD)](https://nobleid.org/work/w1/20260515/332FCBFD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Josef S Smolen

Chenglong Han

Désirée van der Heijde

Claim authorship of this work

Infliximab treatment maintains employability in patients with early rheumatoid arthritis.

Identifier:nobleid.org/w1/20260515/332FCBFD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/332FCBFD.svg?ark=w1%2F20260515%2F332FCBFD)](https://nobleid.org/work/w1/20260515/332FCBFD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Josef S Smolen

Chenglong Han

Désirée van der Heijde

Claim authorship of this work